During the past decade research into the pharmacology of cognition,
particularly regarding learning and memory, has supported the concept
that many potential neural targets exist for the development of
cognitive-enhancing drugs. Whereas the main impetus for this research
has been the ever growing population of individuals with dementing
disorders such as Alzheimer`s disease, attention is also being focused
on issues relating to cognitive impairment associated with "normal"
aging. This book is useful as a source of information for making
informed decisions regarding the relative utility and attributes of the
various neural targets that have been studied to date.